Clinical Trials on Propofol Plasma Concentration in Sweden
Total 117 results
-
Uppsala UniversityForensic Toxicology Laboratory, SwedenCompletedSerum Concentrations | Intoxication | Post Mortem ConcentrationsSweden
-
University Hospital, LinkoepingCompleted
-
University Hospital, LinkoepingUnknownMetabolic Rate | Plasma Glucose | Serum Insulin | Serum Triglycerides | Sense of SatietySweden
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificNetherlands, Sweden, United Kingdom
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, United Kingdom, Belgium, Spain, Sweden
-
Sahlgrenska University Hospital, SwedenCompletedRenal Failure | Inflammatory Response | Hemolysis | Cardiopulmonary Bypass | Extracorporeal Circulation; Complications | Circulation Disorder | Renal Plasma Flow, EffectiveSweden
-
Karolinska InstitutetSanofi; XNK Therapeutics AB, SwedenRecruiting
-
Karolinska University HospitalUnknown
-
Nanexa ABCTC Clinical Trial Consultants ABCompleted
-
Karolinska University HospitalCompleted
-
Hareth NahiCompleted
-
BioInvent International ABTerminated
-
Sundsvall HospitalCompletedMultiple Myeloma | Anemia | Chronic Lymphocytic Leukemia | Non Hodgkin LymphomaSweden
-
Oslo University HospitalNordic Myeloma Study GroupActive, not recruitingMyelomaNorway, Denmark, Sweden
-
SanofiGenzyme, a Sanofi CompanyCompletedMultiple MyelomaSweden, Estonia, Belgium, Lithuania
-
Uppsala UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsCompletedImpact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden (AutoCOVID-19)Covid19 | Hematologic Neoplasms | Stem Cell Transplant Complications | Myeloma Multiple | Malignant LymphomaSweden
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and UusimaaCompletedMultiple Myeloma in RelapseFinland, Sweden
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Netherlands, Sweden, Denmark
-
European Myeloma NetworkCompletedMultiple Myeloma | Hematologic MalignanciesSpain, Sweden, Germany, Italy
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.Unknown
-
BioInvent International ABCompletedMultiple MyelomaDenmark, Belgium, United States, Sweden
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPure Red-cell AplasiaUnited Kingdom, Sweden, South Africa, Brazil, Canada, Germany, Norway, Thailand
-
Nordic Myeloma Study GroupNordic Cancer UnionCompletedMultiple MyelomaDenmark, Norway, Sweden
-
University of MiamiAmgen; Janssen PharmaceuticalsRecruitingMultiple MyelomaUnited States, Sweden
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
Oncopeptides ABTerminatedRelapsed and/or Relapsed-refractory Multiple MyelomaUnited States, Netherlands, Denmark, Sweden, Italy
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Nordic Myeloma Study GroupCompletedMultiple MyelomaDenmark, Sweden, Norway
-
Dr. med. Lars-Olof MueggeTerminatedMultiple MyelomaGermany
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, France, Sweden
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPure Red-cell AplasiaUnited Kingdom, Sweden, South Africa, Brazil, Norway, France, Thailand
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, United Kingdom, Germany, Sweden
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
Janssen-Cilag International NVCompletedMultiple MyelomaTurkey, Greece, Czech Republic, Austria, Germany, Sweden, United Kingdom, Denmark
-
Hoffmann-La RocheCompletedMultiple MyelomaSpain, Denmark, Netherlands, Sweden, Poland, France, Germany, Czechia, Norway
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, Austria, Greece, Netherlands, Sweden
-
Janssen-Cilag Pty LtdCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, United Kingdom, Sweden
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Poland, Greece, Australia, Sweden
-
Merck Sharp & Dohme LLCWithdrawnMultiple MyelomaUnited States, Canada, France, Israel, Spain, Sweden
-
CelgeneRecruitingMultiple MyelomaUnited States, Spain, Sweden, Germany, Italy, Japan
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
Novartis PharmaceuticalsNo longer availableMultiple MyelomaGermany, Austria, Canada, Jordan, Norway, Sweden